Literature DB >> 28757538

The Roles of Hypoxia Signaling in the Pathogenesis of Cardiovascular Diseases.

Hajime Abe1, Hiroaki Semba1,2, Norihiko Takeda1.   

Abstract

The circulatory system distributes blood flow to each tissue and transports oxygen and nutrients. Peripheral circulation is required to maintain the physiological function in each tissue. Disturbance of circulation, therefore, decreases oxygen delivery, leading to tissue hypoxia which takes place in several cardiovascular disorders including atherosclerosis, pulmonary arterial hypertension and heart failure. While tissue hypoxia can be induced because of cardiovascular disorders, hypoxia signaling itself has a potential to modulate tissue remodeling processes or the severity of the cardiovascular disorders. Hypoxia inducible factor-1α (HIF-1α) and HIF-2α belongs to a group of transcription factors which mediate most of the cellular responses to hypoxia at a transcriptional level. We, and others, have reported that HIF-α signaling plays a critical role in the initiation or the regulation of inflammation. HIF-α signaling contributes to the tissue remodeling processes; thus it has a potential to become a therapeutic target. Elucidation of the molecular link, therefore, between hypoxia signaling and tissue remodeling will greatly help us to understand the pathophysiology of the cardiovascular disorders. The purpose of this review is to give a brief overview of the current understanding about the function HIF-α in inflammation processes especially by focusing on its roles in macrophages. In addition, the pathophysiological roles of hypoxia signaling for the development of cardiovascular disease will be discussed.

Entities:  

Keywords:  Cardiovascular diseases; HIF-1α; Hypoxia; Inflammation

Mesh:

Substances:

Year:  2017        PMID: 28757538      PMCID: PMC5587513          DOI: 10.5551/jat.RV17009

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  95 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 2.  Role of endothelial cell metabolism in vessel sprouting.

Authors:  Katrien De Bock; Maria Georgiadou; Peter Carmeliet
Journal:  Cell Metab       Date:  2013-08-22       Impact factor: 27.287

3.  Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes.

Authors:  M G Bonecini-Almeida; S Chitale; I Boutsikakis; J Geng; H Doo; S He; J L Ho
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Inflammation and incident-isolated systolic hypertension in older adults: the Rotterdam study.

Authors:  Francesco U S Mattace-Raso; Germaine C Verwoert; Albert Hofman; Jacqueline C M Witteman
Journal:  J Hypertens       Date:  2010-05       Impact factor: 4.844

Review 6.  Guanylate cyclase and the .NO/cGMP signaling pathway.

Authors:  J W Denninger; M A Marletta
Journal:  Biochim Biophys Acta       Date:  1999-05-05

7.  Changes in MCT 1, MCT 4, and LDH expression are tissue specific in rats after long-term hypobaric hypoxia.

Authors:  Grant B McClelland; George A Brooks
Journal:  J Appl Physiol (1985)       Date:  2002-04

8.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

9.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

Review 10.  The role of hypoxia-inducible factor 1 in atherosclerosis.

Authors:  Linggen Gao; Qian Chen; Xianliang Zhou; Li Fan
Journal:  J Clin Pathol       Date:  2012-05-08       Impact factor: 3.411

View more
  46 in total

1.  Spexin protects cardiomyocytes from hypoxia-induced metabolic and mitochondrial dysfunction.

Authors:  Yang Liu; Li Sun; Linqun Zheng; Mengqi Su; He Liu; Ying Wei; Dan Li; Yike Wang; Chenguang Dai; Yongtai Gong; Chenyang Zhao; Yue Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-08       Impact factor: 3.000

2.  Hypoxia inducible factor 1α inhibitor PX-478 reduces atherosclerosis in mice.

Authors:  Nicolas Villa-Roel; Kitae Ryu; Lina Gu; Joan Fernandez Esmerats; Dong-Won Kang; Sandeep Kumar; Hanjoong Jo
Journal:  Atherosclerosis       Date:  2022-01-21       Impact factor: 5.162

3.  Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress.

Authors:  Brittany G Durgin; Katherine C Wood; Scott A Hahn; Brenda McMahon; Jeffrey J Baust; Adam C Straub
Journal:  J Mol Cell Cardiol       Date:  2021-09-15       Impact factor: 5.000

4.  Altered PVN-to-CA2 hippocampal oxytocin pathway and reduced number of oxytocin-receptor expressing astrocytes in heart failure rats.

Authors:  Ferdinand Althammer; Ranjan K Roy; Arthur Lefevre; Rami S Najjar; Kai Schoenig; Dusan Bartsch; Marina Eliava; Rafaela G Feresin; Elizabeth A D Hammock; Anne Z Murphy; Alexandre Charlet; Valery Grinevich; Javier E Stern
Journal:  J Neuroendocrinol       Date:  2022-06-03       Impact factor: 3.870

5.  Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling.

Authors:  Arne Schmidt; Maximilian Fuchs; Stevan D Stojanović; Chunguang Liang; Kevin Schmidt; Mira Jung; Ke Xiao; Jan Weusthoff; Annette Just; Angelika Pfanne; Jörg H W Distler; Thomas Dandekar; Jan Fiedler; Thomas Thum; Meik Kunz
Journal:  Front Cardiovasc Med       Date:  2022-06-17

6.  c-Jun promotes the survival of H9c2 cells under hypoxia via PTEN/Akt signaling pathway.

Authors:  Fan Wu; Feng Gao; Siyi He; Yunhan Jiang; Guiping Luo; Yingbin Xiao
Journal:  J Physiol Biochem       Date:  2019-08-03       Impact factor: 4.158

7.  A sex-specific evolutionary interaction between ADCY9 and CETP.

Authors:  Isabel Gamache; Marc-André Legault; Jean-Christophe Grenier; Rocio Sanchez; Eric Rhéaume; Samira Asgari; Amina Barhdadi; Yassamin Feroz Zada; Holly Trochet; Yang Luo; Leonid Lecca; Megan Murray; Soumya Raychaudhuri; Jean-Claude Tardif; Marie-Pierre Dubé; Julie Hussin
Journal:  Elife       Date:  2021-10-05       Impact factor: 8.140

Review 8.  Pathophysiological implications of hypoxia in human diseases.

Authors:  Pai-Sheng Chen; Wen-Tai Chiu; Pei-Ling Hsu; Shih-Chieh Lin; I-Chen Peng; Chia-Yih Wang; Shaw-Jenq Tsai
Journal:  J Biomed Sci       Date:  2020-05-11       Impact factor: 8.410

9.  Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway.

Authors:  Pengbo Sun; Yangyang Wang; Yipei Ding; Jingyi Luo; Jin Zhong; Naihan Xu; Yaou Zhang; Weidong Xie
Journal:  iScience       Date:  2021-05-07

10.  Phosphodiesterases Expression during Murine Cardiac Development.

Authors:  Thays Maria da Conceição Silva Carvalho; Silvia Cardarelli; Mauro Giorgi; Andrea Lenzi; Andrea M Isidori; Fabio Naro
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.